nodes	percent_of_prediction	percent_of_DWPC	metapath
Adinazolam—GABRR3—retina—malignant glioma	0.021	0.0328	CbGeAlD
Adinazolam—GABRR2—retina—malignant glioma	0.0182	0.0284	CbGeAlD
Adinazolam—GABRR1—retina—malignant glioma	0.0175	0.0274	CbGeAlD
Adinazolam—GABRA6—brainstem—malignant glioma	0.0151	0.0236	CbGeAlD
Adinazolam—GABRD—telencephalon—malignant glioma	0.014	0.0219	CbGeAlD
Adinazolam—GABRG1—telencephalon—malignant glioma	0.0135	0.0211	CbGeAlD
Adinazolam—GABRA6—telencephalon—malignant glioma	0.0134	0.0209	CbGeAlD
Adinazolam—GABRB1—telencephalon—malignant glioma	0.0131	0.0204	CbGeAlD
Adinazolam—GABRA5—telencephalon—malignant glioma	0.013	0.0203	CbGeAlD
Adinazolam—GABRA4—telencephalon—malignant glioma	0.0118	0.0184	CbGeAlD
Adinazolam—GABRB2—brainstem—malignant glioma	0.0111	0.0174	CbGeAlD
Adinazolam—GABRD—medulla oblongata—malignant glioma	0.011	0.0172	CbGeAlD
Adinazolam—GABRG1—medulla oblongata—malignant glioma	0.0106	0.0165	CbGeAlD
Adinazolam—GABRB1—medulla oblongata—malignant glioma	0.0103	0.016	CbGeAlD
Adinazolam—GABRA2—brainstem—malignant glioma	0.0101	0.0159	CbGeAlD
Adinazolam—GABRD—midbrain—malignant glioma	0.01	0.0157	CbGeAlD
Adinazolam—GABRG2—telencephalon—malignant glioma	0.00985	0.0154	CbGeAlD
Adinazolam—GABRB2—telencephalon—malignant glioma	0.00985	0.0154	CbGeAlD
Adinazolam—GABRA1—brainstem—malignant glioma	0.0098	0.0153	CbGeAlD
Adinazolam—GABRG1—midbrain—malignant glioma	0.00967	0.0151	CbGeAlD
Adinazolam—GABRG3—central nervous system—malignant glioma	0.0096	0.015	CbGeAlD
Adinazolam—GABRG1—spinal cord—malignant glioma	0.00943	0.0148	CbGeAlD
Adinazolam—GABRB1—midbrain—malignant glioma	0.00938	0.0147	CbGeAlD
Adinazolam—GABRR2—cerebellum—malignant glioma	0.00929	0.0145	CbGeAlD
Adinazolam—GABRR1—central nervous system—malignant glioma	0.00915	0.0143	CbGeAlD
Adinazolam—GABRB1—spinal cord—malignant glioma	0.00915	0.0143	CbGeAlD
Adinazolam—GABRA2—telencephalon—malignant glioma	0.009	0.0141	CbGeAlD
Adinazolam—GABRA1—telencephalon—malignant glioma	0.0087	0.0136	CbGeAlD
Adinazolam—GABRD—central nervous system—malignant glioma	0.00795	0.0124	CbGeAlD
Adinazolam—GABRD—cerebellum—malignant glioma	0.00777	0.0122	CbGeAlD
Adinazolam—GABRG2—medulla oblongata—malignant glioma	0.00774	0.0121	CbGeAlD
Adinazolam—GABRB2—medulla oblongata—malignant glioma	0.00774	0.0121	CbGeAlD
Adinazolam—GABRG1—central nervous system—malignant glioma	0.00765	0.012	CbGeAlD
Adinazolam—GABRG3—brain—malignant glioma	0.00762	0.0119	CbGeAlD
Adinazolam—GABRA6—central nervous system—malignant glioma	0.00761	0.0119	CbGeAlD
Adinazolam—GABRB3—telencephalon—malignant glioma	0.00757	0.0118	CbGeAlD
Adinazolam—GABRG1—cerebellum—malignant glioma	0.00748	0.0117	CbGeAlD
Adinazolam—GABRA6—cerebellum—malignant glioma	0.00744	0.0116	CbGeAlD
Adinazolam—GABRB1—central nervous system—malignant glioma	0.00742	0.0116	CbGeAlD
Adinazolam—GABRA5—central nervous system—malignant glioma	0.00738	0.0115	CbGeAlD
Adinazolam—GABRR1—brain—malignant glioma	0.00726	0.0114	CbGeAlD
Adinazolam—GABRB1—cerebellum—malignant glioma	0.00725	0.0113	CbGeAlD
Adinazolam—GABRB2—midbrain—malignant glioma	0.00708	0.0111	CbGeAlD
Adinazolam—GABRG2—midbrain—malignant glioma	0.00708	0.0111	CbGeAlD
Adinazolam—GABRB2—spinal cord—malignant glioma	0.0069	0.0108	CbGeAlD
Adinazolam—GABRG2—spinal cord—malignant glioma	0.0069	0.0108	CbGeAlD
Adinazolam—GABRA3—central nervous system—malignant glioma	0.00687	0.0107	CbGeAlD
Adinazolam—GABRA1—medulla oblongata—malignant glioma	0.00684	0.0107	CbGeAlD
Adinazolam—GABRA4—central nervous system—malignant glioma	0.0067	0.0105	CbGeAlD
Adinazolam—GABRA4—cerebellum—malignant glioma	0.00654	0.0102	CbGeAlD
Adinazolam—GABRD—brain—malignant glioma	0.00631	0.00987	CbGeAlD
Adinazolam—GABRA1—midbrain—malignant glioma	0.00625	0.00977	CbGeAlD
Adinazolam—GABRA1—spinal cord—malignant glioma	0.0061	0.00954	CbGeAlD
Adinazolam—GABRG1—brain—malignant glioma	0.00608	0.0095	CbGeAlD
Adinazolam—GABRA6—brain—malignant glioma	0.00604	0.00945	CbGeAlD
Adinazolam—GABRB3—medulla oblongata—malignant glioma	0.00595	0.0093	CbGeAlD
Adinazolam—GABRB1—brain—malignant glioma	0.00589	0.00921	CbGeAlD
Adinazolam—GABRA5—brain—malignant glioma	0.00586	0.00917	CbGeAlD
Adinazolam—GABRG2—central nervous system—malignant glioma	0.0056	0.00876	CbGeAlD
Adinazolam—GABRB2—central nervous system—malignant glioma	0.0056	0.00876	CbGeAlD
Adinazolam—GABRG2—cerebellum—malignant glioma	0.00547	0.00856	CbGeAlD
Adinazolam—GABRB2—cerebellum—malignant glioma	0.00547	0.00856	CbGeAlD
Adinazolam—GABRA3—brain—malignant glioma	0.00545	0.00853	CbGeAlD
Adinazolam—GABRB3—midbrain—malignant glioma	0.00543	0.0085	CbGeAlD
Adinazolam—GABRA4—brain—malignant glioma	0.00532	0.00831	CbGeAlD
Adinazolam—GABRB3—spinal cord—malignant glioma	0.0053	0.00829	CbGeAlD
Adinazolam—Clobazam—CYP2C18—malignant glioma	0.00518	0.173	CrCbGaD
Adinazolam—GABRA2—central nervous system—malignant glioma	0.00512	0.008	CbGeAlD
Adinazolam—GABRE—central nervous system—malignant glioma	0.00507	0.00794	CbGeAlD
Adinazolam—GABRA2—cerebellum—malignant glioma	0.005	0.00782	CbGeAlD
Adinazolam—GABRA1—central nervous system—malignant glioma	0.00495	0.00774	CbGeAlD
Adinazolam—GABRA1—cerebellum—malignant glioma	0.00483	0.00756	CbGeAlD
Adinazolam—GABRB2—brain—malignant glioma	0.00445	0.00696	CbGeAlD
Adinazolam—GABRG2—brain—malignant glioma	0.00445	0.00696	CbGeAlD
Adinazolam—GABRB3—central nervous system—malignant glioma	0.0043	0.00673	CbGeAlD
Adinazolam—GABRB3—cerebellum—malignant glioma	0.0042	0.00658	CbGeAlD
Adinazolam—GABRA2—brain—malignant glioma	0.00406	0.00635	CbGeAlD
Adinazolam—GABRE—brain—malignant glioma	0.00403	0.0063	CbGeAlD
Adinazolam—GABRA1—brain—malignant glioma	0.00393	0.00614	CbGeAlD
Adinazolam—Clobazam—CYP2B6—malignant glioma	0.00384	0.128	CrCbGaD
Adinazolam—Clomipramine—GSTP1—malignant glioma	0.00361	0.121	CrCbGaD
Adinazolam—Flunitrazepam—CYP2B6—malignant glioma	0.00352	0.118	CrCbGaD
Adinazolam—GABRB3—brain—malignant glioma	0.00341	0.00534	CbGeAlD
Adinazolam—Diazepam—CYP2C18—malignant glioma	0.00302	0.101	CrCbGaD
Adinazolam—Temazepam—CYP2B6—malignant glioma	0.0027	0.0903	CrCbGaD
Adinazolam—Midazolam—CYP2B6—malignant glioma	0.00262	0.0875	CrCbGaD
Adinazolam—Diazepam—CYP2B6—malignant glioma	0.00224	0.075	CrCbGaD
Adinazolam—CYP3A4—central nervous system—malignant glioma	0.0022	0.00344	CbGeAlD
Adinazolam—Chlorpromazine—BCHE—malignant glioma	0.0017	0.0569	CrCbGaD
Adinazolam—Diazepam—PTGS1—malignant glioma	0.00148	0.0493	CrCbGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000469	0.00142	CbGpPWpGaD
Adinazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000467	0.00141	CbGpPWpGaD
Adinazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000464	0.0014	CbGpPWpGaD
Adinazolam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000462	0.0014	CbGpPWpGaD
Adinazolam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.00046	0.00139	CbGpPWpGaD
Adinazolam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000456	0.00138	CbGpPWpGaD
Adinazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000455	0.00138	CbGpPWpGaD
Adinazolam—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000455	0.00137	CbGpPWpGaD
Adinazolam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000455	0.00137	CbGpPWpGaD
Adinazolam—GABRR2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000452	0.00137	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000451	0.00136	CbGpPWpGaD
Adinazolam—GABRR2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000451	0.00136	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—BCHE—malignant glioma	0.000449	0.00136	CbGpPWpGaD
Adinazolam—GABRG3—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000445	0.00134	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.000441	0.00133	CbGpPWpGaD
Adinazolam—GABRG3—Ion channel transport—RAF1—malignant glioma	0.00044	0.00133	CbGpPWpGaD
Adinazolam—GABRB1—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000438	0.00132	CbGpPWpGaD
Adinazolam—GABRR1—Neuronal System—BRAF—malignant glioma	0.000434	0.00131	CbGpPWpGaD
Adinazolam—GABRB1—Ion channel transport—RAF1—malignant glioma	0.000433	0.00131	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000431	0.0013	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.00043	0.0013	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—SLC6A3—malignant glioma	0.000422	0.00128	CbGpPWpGaD
Adinazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000417	0.00126	CbGpPWpGaD
Adinazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000416	0.00126	CbGpPWpGaD
Adinazolam—GABRA6—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000415	0.00125	CbGpPWpGaD
Adinazolam—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000414	0.00125	CbGpPWpGaD
Adinazolam—GABRR2—Neuronal System—BRAF—malignant glioma	0.000414	0.00125	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.00041	0.00124	CbGpPWpGaD
Adinazolam—GABRA6—Ion channel transport—RAF1—malignant glioma	0.00041	0.00124	CbGpPWpGaD
Adinazolam—GABRA4—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000409	0.00124	CbGpPWpGaD
Adinazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000405	0.00123	CbGpPWpGaD
Adinazolam—GABRA4—Ion channel transport—RAF1—malignant glioma	0.000404	0.00122	CbGpPWpGaD
Adinazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000404	0.00122	CbGpPWpGaD
Adinazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000398	0.0012	CbGpPWpGaD
Adinazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000398	0.0012	CbGpPWpGaD
Adinazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000397	0.0012	CbGpPWpGaD
Adinazolam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000392	0.00118	CbGpPWpGaD
Adinazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000391	0.00118	CbGpPWpGaD
Adinazolam—CYP2C19—Biological oxidations—GSTT1—malignant glioma	0.00039	0.00118	CbGpPWpGaD
Adinazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.00039	0.00118	CbGpPWpGaD
Adinazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000389	0.00117	CbGpPWpGaD
Adinazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000387	0.00117	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000386	0.00117	CbGpPWpGaD
Adinazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000382	0.00115	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.00038	0.00115	CbGpPWpGaD
Adinazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.00038	0.00115	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—RAF1—malignant glioma	0.000379	0.00114	CbGpPWpGaD
Adinazolam—CYP2C19—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000377	0.00114	CbGpPWpGaD
Adinazolam—GABRB2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000374	0.00113	CbGpPWpGaD
Adinazolam—GABRG3—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000373	0.00113	CbGpPWpGaD
Adinazolam—GABRG3—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000371	0.00112	CbGpPWpGaD
Adinazolam—GABRB2—Ion channel transport—RAF1—malignant glioma	0.00037	0.00112	CbGpPWpGaD
Adinazolam—GABRB1—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000367	0.00111	CbGpPWpGaD
Adinazolam—GABRB1—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000366	0.00111	CbGpPWpGaD
Adinazolam—CYP2C19—Biological oxidations—PTGS1—malignant glioma	0.000366	0.00111	CbGpPWpGaD
Adinazolam—GABRA5—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000364	0.0011	CbGpPWpGaD
Adinazolam—GABRR1—Neuronal System—MDM2—malignant glioma	0.000363	0.0011	CbGpPWpGaD
Adinazolam—GABRR1—Neuronal System—RAF1—malignant glioma	0.000362	0.00109	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—TFRC—malignant glioma	0.00036	0.00109	CbGpPWpGaD
Adinazolam—GABRA5—Ion channel transport—RAF1—malignant glioma	0.000359	0.00109	CbGpPWpGaD
Adinazolam—GABRA3—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000357	0.00108	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000355	0.00107	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000355	0.00107	CbGpPWpGaD
Adinazolam—GABRA3—Ion channel transport—RAF1—malignant glioma	0.000353	0.00107	CbGpPWpGaD
Adinazolam—GABRA2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000351	0.00106	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000349	0.00106	CbGpPWpGaD
Adinazolam—GABRB3—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000349	0.00105	CbGpPWpGaD
Adinazolam—GABRA6—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000347	0.00105	CbGpPWpGaD
Adinazolam—GABRA2—Ion channel transport—RAF1—malignant glioma	0.000347	0.00105	CbGpPWpGaD
Adinazolam—GABRR2—Neuronal System—MDM2—malignant glioma	0.000347	0.00105	CbGpPWpGaD
Adinazolam—GABRA6—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000346	0.00105	CbGpPWpGaD
Adinazolam—GABRR2—Neuronal System—RAF1—malignant glioma	0.000345	0.00104	CbGpPWpGaD
Adinazolam—GABRB3—Ion channel transport—RAF1—malignant glioma	0.000345	0.00104	CbGpPWpGaD
Adinazolam—GABRA4—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000343	0.00104	CbGpPWpGaD
Adinazolam—GABRG2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000342	0.00104	CbGpPWpGaD
Adinazolam—GABRA4—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000342	0.00103	CbGpPWpGaD
Adinazolam—GABRG3—Neuronal System—BRAF—malignant glioma	0.000341	0.00103	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—CASP3—malignant glioma	0.00034	0.00103	CbGpPWpGaD
Adinazolam—GABRG2—Ion channel transport—RAF1—malignant glioma	0.000338	0.00102	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000338	0.00102	CbGpPWpGaD
Adinazolam—GABRB1—Neuronal System—BRAF—malignant glioma	0.000336	0.00101	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000335	0.00101	CbGpPWpGaD
Adinazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000334	0.00101	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000332	0.00101	CbGpPWpGaD
Adinazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000332	0.001	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000331	0.000999	CbGpPWpGaD
Adinazolam—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.00033	0.000998	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000326	0.000987	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000325	0.000983	CbGpPWpGaD
Adinazolam—GABRA6—Neuronal System—BRAF—malignant glioma	0.000318	0.00096	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000316	0.000955	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000315	0.000951	CbGpPWpGaD
Adinazolam—GABRB2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000314	0.000948	CbGpPWpGaD
Adinazolam—GABRA4—Neuronal System—BRAF—malignant glioma	0.000314	0.000948	CbGpPWpGaD
Adinazolam—GABRB2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000313	0.000945	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000311	0.000939	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—TFRC—malignant glioma	0.00031	0.000937	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000305	0.000921	CbGpPWpGaD
Adinazolam—GABRA5—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000305	0.000921	CbGpPWpGaD
Adinazolam—GABRA5—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000304	0.000918	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000303	0.000915	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000299	0.000905	CbGpPWpGaD
Adinazolam—GABRA3—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000299	0.000905	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000298	0.000902	CbGpPWpGaD
Adinazolam—GABRA3—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000298	0.000901	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000297	0.000899	CbGpPWpGaD
Adinazolam—GABRA1—Ion channel transport—RAF1—malignant glioma	0.000296	0.000894	CbGpPWpGaD
Adinazolam—GABRA2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000294	0.000889	CbGpPWpGaD
Adinazolam—GABRA2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000293	0.000886	CbGpPWpGaD
Adinazolam—GABRB3—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000292	0.000883	CbGpPWpGaD
Adinazolam—GABRB3—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000291	0.00088	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.00029	0.000877	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.00029	0.000877	CbGpPWpGaD
Adinazolam—GABRG2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000287	0.000867	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—BRAF—malignant glioma	0.000287	0.000867	CbGpPWpGaD
Adinazolam—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000286	0.000865	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000286	0.000865	CbGpPWpGaD
Adinazolam—GABRG2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000286	0.000864	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—STAT3—malignant glioma	0.000286	0.000864	CbGpPWpGaD
Adinazolam—GABRG3—Neuronal System—MDM2—malignant glioma	0.000285	0.000863	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000285	0.000861	CbGpPWpGaD
Adinazolam—GABRG3—Neuronal System—RAF1—malignant glioma	0.000285	0.00086	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000284	0.000859	CbGpPWpGaD
Adinazolam—GABRB1—Neuronal System—MDM2—malignant glioma	0.000281	0.00085	CbGpPWpGaD
Adinazolam—GABRB1—Neuronal System—RAF1—malignant glioma	0.00028	0.000847	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.00028	0.000846	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—BRAF—malignant glioma	0.000279	0.000842	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000278	0.00084	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000276	0.000834	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000274	0.000829	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000274	0.000828	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—BRAF—malignant glioma	0.000274	0.000827	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—RTEL1—malignant glioma	0.000274	0.000827	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000273	0.000825	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000271	0.000819	CbGpPWpGaD
Adinazolam—CYP2C19—Biological oxidations—GSTP1—malignant glioma	0.000271	0.000818	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—BRAF—malignant glioma	0.000269	0.000813	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—BRAF—malignant glioma	0.000267	0.000808	CbGpPWpGaD
Adinazolam—CYP2C19—Metapathway biotransformation—GSTP1—malignant glioma	0.000267	0.000807	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000266	0.000805	CbGpPWpGaD
Adinazolam—GABRA6—Neuronal System—MDM2—malignant glioma	0.000266	0.000805	CbGpPWpGaD
Adinazolam—GABRA6—Neuronal System—RAF1—malignant glioma	0.000265	0.000802	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000265	0.0008	CbGpPWpGaD
Adinazolam—GABRA4—Neuronal System—MDM2—malignant glioma	0.000263	0.000794	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—BRAF—malignant glioma	0.000262	0.000793	CbGpPWpGaD
Adinazolam—GABRA4—Neuronal System—RAF1—malignant glioma	0.000262	0.000792	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.00026	0.000786	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.00026	0.000786	CbGpPWpGaD
Adinazolam—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000251	0.000759	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000251	0.000758	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—RAF1—malignant glioma	0.00025	0.000755	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—MDM2—malignant glioma	0.00024	0.000727	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—RAF1—malignant glioma	0.000239	0.000724	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000239	0.000721	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000235	0.00071	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—MDM2—malignant glioma	0.000233	0.000706	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—RAF1—malignant glioma	0.000233	0.000703	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000232	0.000702	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—BRAF—malignant glioma	0.000229	0.000693	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—MDM2—malignant glioma	0.000229	0.000693	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—RAF1—malignant glioma	0.000228	0.000691	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000227	0.000687	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—MDM2—malignant glioma	0.000225	0.000681	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—RAF1—malignant glioma	0.000225	0.000679	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—MDM2—malignant glioma	0.000224	0.000677	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—RAF1—malignant glioma	0.000223	0.000674	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.00022	0.000665	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—MDM2—malignant glioma	0.00022	0.000664	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—RAF1—malignant glioma	0.000219	0.000662	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000199	0.000602	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000195	0.000591	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000195	0.000589	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—MDM2—malignant glioma	0.000192	0.000581	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—RAF1—malignant glioma	0.000191	0.000579	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000189	0.000572	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000186	0.000562	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—AKT1—malignant glioma	0.000184	0.000557	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000164	0.000497	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000163	0.000492	CbGpPWpGaD
Adinazolam—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.00016	0.000485	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—COX8A—malignant glioma	0.000157	0.000475	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000153	0.000462	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000151	0.000456	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000143	0.000431	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000141	0.000426	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.00014	0.000425	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—ASMT—malignant glioma	0.000134	0.000404	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000131	0.000395	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000129	0.000389	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—BCAN—malignant glioma	0.000126	0.00038	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000125	0.000378	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000123	0.000371	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000121	0.000365	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—RAF1—malignant glioma	0.00012	0.000363	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000118	0.000356	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000103	0.000311	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—IDH2—malignant glioma	0.000101	0.000306	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	9.55e-05	0.000289	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CYP2B6—malignant glioma	9.52e-05	0.000288	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—COX8A—malignant glioma	9.45e-05	0.000286	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—IDH1—malignant glioma	8.7e-05	0.000263	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—SPHK1—malignant glioma	8.42e-05	0.000255	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CYP2C18—malignant glioma	8.25e-05	0.000249	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—ASMT—malignant glioma	8.03e-05	0.000243	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	7.78e-05	0.000235	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—BCAN—malignant glioma	7.55e-05	0.000228	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	7.09e-05	0.000214	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	6.84e-05	0.000207	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—GSTT1—malignant glioma	6.67e-05	0.000202	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PTGS1—malignant glioma	6.25e-05	0.000189	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6.23e-05	0.000188	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—IDH2—malignant glioma	6.09e-05	0.000184	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—BCHE—malignant glioma	5.81e-05	0.000176	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—SLC5A5—malignant glioma	5.74e-05	0.000174	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CYP2B6—malignant glioma	5.72e-05	0.000173	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.43e-05	0.000164	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.38e-05	0.000163	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—IDH1—malignant glioma	5.23e-05	0.000158	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—SPHK1—malignant glioma	5.07e-05	0.000153	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CYP2C18—malignant glioma	4.96e-05	0.00015	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.69e-05	0.000142	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—GSTP1—malignant glioma	4.63e-05	0.00014	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CAT—malignant glioma	4.5e-05	0.000136	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—NCOR1—malignant glioma	4.25e-05	0.000129	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GSTT1—malignant glioma	4.01e-05	0.000121	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PTGS1—malignant glioma	3.76e-05	0.000114	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—BCHE—malignant glioma	3.5e-05	0.000106	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CAV1—malignant glioma	3.47e-05	0.000105	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—SLC5A5—malignant glioma	3.45e-05	0.000104	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.31e-05	0.0001	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PIK3CG—malignant glioma	3.16e-05	9.54e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PPARG—malignant glioma	3.05e-05	9.21e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GSTP1—malignant glioma	2.78e-05	8.41e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PIK3CD—malignant glioma	2.77e-05	8.39e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CAT—malignant glioma	2.71e-05	8.18e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—NCOR1—malignant glioma	2.56e-05	7.73e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PIK3CB—malignant glioma	2.42e-05	7.31e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PTGS2—malignant glioma	2.4e-05	7.25e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PTEN—malignant glioma	2.09e-05	6.32e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CAV1—malignant glioma	2.08e-05	6.3e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.9e-05	5.74e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PPARG—malignant glioma	1.83e-05	5.54e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.67e-05	5.05e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PIK3CA—malignant glioma	1.47e-05	4.46e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.45e-05	4.4e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PTGS2—malignant glioma	1.44e-05	4.36e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PTEN—malignant glioma	1.26e-05	3.8e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—AKT1—malignant glioma	1.2e-05	3.64e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PIK3CA—malignant glioma	8.87e-06	2.68e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—AKT1—malignant glioma	7.24e-06	2.19e-05	CbGpPWpGaD
